Sfoglia per AUTORE
TORRI V
Collezione ASL Biella

  

Items : 5

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. in Tumori / Tumori. 2024 Jun;110(3):168-173. doi: 10.1177/03008916241229287. Epub 2024 Feb 19.

2024
ASL Cuneo 2
AOU Alessandria
ASL Città di Torino
ASL Biella

Grosso F; Garassino MC; Ceresoli GL; Pasello G; Petraglia S; De Simone I; Cuppone F; Gauna R; Verderame F; Alabiso I; Dellepiane C; Biello F; Lo Russo G; Occhipinti M; Proto C; Mazzeo L; De Angelis AM; Torri V; Crivellari S; Delfanti S; Cerbone L;

Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. in ESMO open / ESMO Open. 2020 Sep;5(5):e000911. doi: 10.1136/esmoopen-2020-000911.

2020
ASL Biella

Sartore-Bianchi A; Lonardi S; Martino C; Fenocchio E; Tosi F; Ghezzi S; Leone F; Bergamo F; Zagonel V; Ciardiello F; Ardizzoni A; Amatu A; Bencardino K; Valtorta E; Grassi E; Torri V; Bonoldi E; Sapino A; Vanzulli A; Regge D; Cappello G; Bardelli A; Trusolino L; Marsoni S; Siena S;

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. in Clinical colorectal cancer / Clin Colorectal Cancer. 2020 Dec;19(4):256-262.e2. doi: 10.1016/j.clcc.2020.06.009. Epub 2020 Jun 27

2020
ASL Biella

Tosi F; Sartore-Bianchi A; Lonardi S; Amatu A; Leone F; Ghezzi S; Martino C; Bencardino K; Bonazzina E; Bergamo F; Fenocchio E; Martinelli E; Troiani T; Siravegna G; Mauri G; Torri V; Marrapese G; Valtorta E; Cassingena A; Cappello G; Bonoldi E; Vanzulli A; Regge D; Ciardiello F; Zagonel V; Bardelli A; Trusolino L; Marsoni S; Siena S; et alii...

Early progression of disease (POD24) predicts shorter survival in malt lymphoma patients receiving systemic treatment in Hematological Oncology

2019
ASL Biella

Conconi A; Thieblemont C; Cascione L; Torri V; Kiesewetter B; Margiotta-Casaluci G; Gaidano G; Raderer M; Cavalli F; Lopez Guillermo A; Johnson PW; Zucca E;

Early progression of disease (POD24) as survival predictor in MALT lymphoma in Journal of Clinical Oncology

2019
ASL Biella

Conconi A; Thieblemont C; Cascione L; Torri V; Kiesewetter B; Margiotta-Casaluci G; Gaidano G; Raderer M; Cavalli F; Lopez-Guillermo A; Johnson PWM; Zucca E;